Advertisement

Topics

GTx Announced New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence

22:03 EST 4 Mar 2018 | Drugs.com

MEMPHIS, Tenn.--(BUSINESS WIRE)--Mar. 5, 2018-- GTx, Inc. (Nasdaq:GTXI) today announced additional results from a Phase 2 proof-of-concept clinical trial of 3 mg enobosarm administered orally in postmenopausal women with stress urinary incontinence...

Original Article: GTx Announced New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence

NEXT ARTICLE

More From BioPortfolio on "GTx Announced New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...